Uniform and blinded cause of death verification of the NELSON lung cancer screening participants

Lung Cancer

Volumn 111, Issue , 2017, Pages 131-134

  Yousaf Khan, A U ^a   van der Aalst, C M ^a   Aerts, J G J V ^a,b   den Bakker, M A ^c   de Koning, H J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b AMPHIA HOSPITAL   (Netherlands)

^c Maasstad Hospital   (Netherlands)

Author keywords

Cause of death; Computed tomography; Early detection of cancer; Lung cancer; Lung cancer screening

Indexed keywords

ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER SCREENING; CAUSE OF DEATH; DEATH CERTIFICATE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PATIENT IDENTIFICATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; BELGIUM; EARLY CANCER DIAGNOSIS; LUNG TUMOR; MASS SCREENING; MORTALITY; NETHERLANDS; REGISTER;

BELGIUM; CAUSE OF DEATH; DEATH CERTIFICATES; EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; MASS SCREENING; NETHERLANDS; REGISTRIES;

EID: 85026399184     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2017.07.018     Document Type: Article

References (10)

1. Williams, N.J., Hill, E.M., Ng, S.Y., et al. Standardisation of information submitted to an endpoint committee for cause of death assignment in a cancer screening trial − lessons learnt from CAP (Cluster randomised triAl of PSA testing for Prostate cancer). BMC Med. Res. Methodol., 15(6), 2015.
2. Otto, S.J., van Leeuwen, P.J., Hoekstra, J.W., et al. Blinded and uniform causes of death verification in cancer screening: a major influence on the outcome of a prostate cancer screening trial?. Eur. J. Cancer 46:17 (2010), 3061–3067.
3. Marcus, P.M., Gareen f, I., Miller, A.B., et al. The national lung screening trial's endpoint verification process: determining the cause of death. Contemp. Clin. Trials 32:6 (2011), 834–840.
4. Marcus, P.M., Doria-Rose, V.P., Gareen, I.F., et al. Did death certificates and a death review process agree on lung cancer cause of death in the National Lung Screening Trial?. Clin. Trials 13:4 (2016), 434–438.
5. Maudsley, G., Williams, E.M., Death certification by house officers and general practitioners?practice and performance. J. Public Health Med. 15:2 (1993), 192–201.
6. Degani, A.T., Patel, R.M., Smith, B.E., et al. The effect of student training on accuracy of completion of death certificates. Med. Educ. Online, 14(17), 2009.
7. Aung, E., Rao, C., Walker, S., Teaching cause-of-death certification: lessons from international experience. Postgrad. Med. J. 86:1013 (2010), 143–152.
8. van Klaveren, R.J., Oudkerk, M., Prokop, M., et al. Management of lung nodules detected by volume CT scanning. N. Engl. J. Med. 361:23 (2009), 2221–2229.
9. Horeweg, N., van Klaveren, R.J., Groen, H.J.M., et al. Blinded and uniform cause of death verification in a lung cancer CT screening trial. Lung Cancer 77:3 (2012), 522–525.
10. De Koning, H.J., Blom, J., Merkelbach, J.W., et al. Determining the cause of death in randomized screening trial(s) for prostate cancer. BJU Int. 92:2 (2003), 71–78.